Trials / Completed
CompletedNCT04414397
A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old
A Multicenter, Evaluator-blinded, Randomized, Parallel-group, Controlled Study of the Safety and Effectiveness of JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 205 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to evaluate the safety and effectiveness of Juvederm® Voluma® XC injectable gel in adult participants seeking correction of temple hollowing
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM® VOLUMA® XC | JUVÉDERM® VOLUMA® XC injectable gel |
| OTHER | No-treatment control | Participants received no treatment for 3 months during the Control Period. |
Timeline
- Start date
- 2020-05-28
- Primary completion
- 2022-10-17
- Completion
- 2022-10-17
- First posted
- 2020-06-04
- Last updated
- 2024-04-25
- Results posted
- 2024-04-25
Locations
15 sites across 2 countries: United States, Puerto Rico
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04414397. Inclusion in this directory is not an endorsement.